Related Experiment Video
Updated: May 15, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Monitoring oncogenic B-RAF-induced senescence in melanocytes
1Melanoma Institute Australia, North Sydney, Australia.
Abstract:
The B-RAF kinase is a downstream effector of the RAS family of proto-oncogenes and is constitutively activated in the majority of human melanomas. The common oncogenic B-RAF(V600E) mutant cooperates with additional genetic lesions to transform immortal murine and human cells. In primary cells, however, B-RAF(V600E) triggers a rapid cell cycle arrest that is phenotypically indistinguishable from cellular senescence. Here we describe the analyses of B-RAF-induced senescence in primary human melanocytes using recombinant lentiviruses.
Insights
The B-RAF(V600E) mutation, common in melanoma, causes cell cycle arrest resembling senescence in healthy cells. This study analyzes this B-RAF-induced senescence in human melanocytes.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The B-RAF kinase, a RAS pathway effector, is frequently activated in human melanomas.
- The oncogenic B-RAF(V600E) mutation drives melanoma development by cooperating with other genetic changes.
- In primary cells, B-RAF(V600E) induces a cell cycle arrest mimicking cellular senescence.
Purpose of the Study:
- To investigate the mechanisms of B-RAF-induced senescence in primary human melanocytes.
- To analyze the cellular response to the common B-RAF(V600E) mutation in a relevant cell type.
Main Methods:
- Utilized recombinant lentiviruses for gene delivery.
- Studied primary human melanocytes.
- Analyzed B-RAF-induced senescence phenotypes.
Main Results:
- B-RAF(V600E) expression in primary human melanocytes triggers a senescence-like cell cycle arrest.
- This senescence is a significant barrier to transformation by B-RAF(V600E) in non-immortalized cells.
Conclusions:
- Cellular senescence is a critical tumor-suppressive mechanism activated by oncogenic B-RAF in normal melanocytes.
- Understanding B-RAF-induced senescence is crucial for developing effective melanoma therapies.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Replicative Cell Senescence
The Ras Gene
Ras is a superfamily...